CEO: Dan Bradbury
No. of employees: 11
Headquarters: La Jolla
Year Founded: 2017
Stock symbol and exchange: EQ on Nasdaq
Fundraising: In October raised $71.6 million in an initial public offering
Company description: Equillium is developing drugs for potential immuno-inflammatory diseases, including a tissue transplant disease.
Equillium went from founding to a Nasdaq listing in only 16 months, indicating a biotech moving at warp speed...